Health ❯Healthcare ❯Patient Safety

Adverse Effects

Liver Injury Clinical Outcomes Respiratory Depression Drug Side Effects Genetic Variants Reporting Mechanisms Hyperkalemia Monitoring Emergency Room Visits Medication Interactions Drug Tolerability Treatment-Related Adverse Effects Drug Toxicity Blood Testing Monitoring Vaccine Reactions Monitoring and Reporting Vaccine Safety Vaccine Side Effects Probiotic Use Serious Side Effects Thrombosis

7 ARTICLES

2mo ago

FDA Grants Accelerated Approval to Zongertinib for HER2-Mutant Lung Cancer

Fueled by trial-proven high response rates alongside favorable safety, the new approval pairs an oral HER2-selective inhibitor with its companion diagnostic

3 ARTICLES

2mo ago

Pharmacogenetic Screening Halves Severe Chemotherapy Reactions in Gastrointestinal Cancer Patients

7 ARTICLES

2mo ago

Sarepta Halts Elevidys Shipments for Non-Ambulatory Patients After Second Fatal Liver Failure

5 ARTICLES

5mo ago

SYNT-101 Shows Promise in Early Human Trials as a Non-Invasive Obesity Treatment

3 ARTICLES

5mo ago

Obicetrapib Shows Promise in Reducing LDL Cholesterol and Lp(a) in High-Risk Patients

7 ARTICLES

6mo ago

Stem Cell Therapies for Parkinson’s Show Safety and Early Effectiveness in Trials

4 ARTICLES

7mo ago

First Death Reported from Sarepta's Duchenne Gene Therapy Raises Safety Concerns

10 ARTICLES

10mo ago

France Restricts Sale of Eight Popular Cold Medications Over Safety Concerns

6 ARTICLES

10mo ago

Clonazepam Recalled Nationwide Over Potentially Life-Threatening Labeling Error

Adverse Effects

FDA Grants Accelerated Approval to Zongertinib for HER2-Mutant Lung Cancer

Pharmacogenetic Screening Halves Severe Chemotherapy Reactions in Gastrointestinal Cancer Patients

Sarepta Defies FDA, Keeps Duchenne Gene Therapy on the Market

MHRA Warns of Small Guillain-Barré Syndrome Risk With RSV Vaccines

BMJ Reveals Data Flaws in Pivotal Ticagrelor FDA Approval Studies

Sarepta Halts Elevidys Shipments for Non-Ambulatory Patients After Second Fatal Liver Failure

SYNT-101 Shows Promise in Early Human Trials as a Non-Invasive Obesity Treatment

Obicetrapib Shows Promise in Reducing LDL Cholesterol and Lp(a) in High-Risk Patients

Stem Cell Therapies for Parkinson’s Show Safety and Early Effectiveness in Trials

First Death Reported from Sarepta's Duchenne Gene Therapy Raises Safety Concerns

France Restricts Sale of Eight Popular Cold Medications Over Safety Concerns

Clonazepam Recalled Nationwide Over Potentially Life-Threatening Labeling Error